DFTX
NASDAQ · Pharmaceuticals
Definium Therapeutics Inc
$46.14
+0.00 (+0.00%)
Open$46.30
Previous Close$46.14
Day High$49.70
Day Low$44.24
52W High$49.20
52W Low$8.70
Volume—
Avg Volume1.73M
Market Cap6.06B
P/E Ratio—
EPS$-2.49
SectorPharmaceuticals
Analyst Ratings
Strong Buy
23 analysts
Price Target
-0.3% upside
Current
$46.14
$46.14
Target
$46.00
$46.00
$39.37
$46.00 avg
$57.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 685.27M | 628.04M | 535.94M |
| Net Income | 136.42M | 119.21M | 84.03M |
| Profit Margin | 19.9% | 19.0% | 15.7% |
| EBITDA | 222.00M | 198.31M | 161.40M |
| Free Cash Flow | 100.39M | 95.21M | 82.42M |
| Rev Growth | -7.8% | +7.1% | -9.9% |
| Debt/Equity | 0.71 | 0.57 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |